Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A case report

Endocrine Practice

Volumn 14, Issue 7, 2008, Pages 889-891

  Mapas Dimaya, Ann Celeste ^a   Agdere, Levon ^a,b   Bahtiyar, Gul ^a,c   Mejia, Jose O ^a,c,d   Sacerdote, Alan S ^a,c  

^a WOODHULL MEDICAL CENTER   (United States)

^b BROOKLYN HOSPITAL CENTER   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ELECTROLYTE; FLUDROCORTISONE; GLUCOSE; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; METFORMIN; STEROID 21 MONOOXYGENASE; TESTOSTERONE;

ACANTHOSIS NIGRICANS; ADOLESCENT; AMENORRHEA; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CASE REPORT; CLINICAL EVALUATION; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CUSHING SYNDROME; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROLYTE BLOOD LEVEL; EVENING DOSAGE; FEMALE; GENITAL SYSTEM; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; INSULIN RESISTANCE; LABORATORY TEST; MORNING DOSAGE; OBESITY; PHYSICAL EXAMINATION; SALT WASTING; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROID THERAPY; SUBSTITUTION THERAPY; TESTOSTERONE BLOOD LEVEL; TREATMENT RESPONSE; GENETICS; PATHOLOGY;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; FEMALE; HUMANS; METFORMIN; STEROID 21-HYDROXYLASE;

EID: 64749107414     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.7.889     Document Type: Article

References (15)

1. Speiser PW, Serrat J, New MI, Gertner JM. Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1992;75:1421-1424.
2. Saygili F, Oge A, Yilmaz C. Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Horm Res. 2005;63:270-274.
3. Paula FJ, Gouveia LM, Paccola GM, Piccinato CE, Moreira AC, Foss MC. Androgen-related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia. Horm Metab Res. 1994;26:552-556.
4. Sacerdote A, Vergara R, Carnegie B. Do all patients with NIDDM have late-onset congenital adrenal hyperplasia? Presented at the 76th Annual Meeting of The Endocrine Society; June 15-18, 1994; Anaheim, California.
5. Sacerdote AS. Adrenal androgens and NIDDM. Diabetes Care. 1995;18:278-279.
6. Carbunaru G, Prasad P, Scoccia B, et al. The hormonal phenotype of nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency. J Clin Endocrinol Metab. 2004;89:783-794.
7. Osehobo E, Shaw I, Sacerdote A. Do insulin sensitizers repair the gene defects in non-classical congenital adrenal hyperplasia? Presented at the 82nd Annual Meeting of The Endocrine Society; June 21-24, 2000; Toronto, Canada. Abstract 547.
8. Sacerdote A. Weight-dependent expression of non-classical aldosterone synthase deficiency. Presented at the 84th Annual Meeting of The Endocrine Society; June 19-22, 2002; San Francisco, California. Abstract 599.
9. Sacerdote AS, Sanchez JU, Ogbeide O, Slabodkina L. Modification of expression of non-classical congenital adrenal hyperplasia by rosiglitazone. Presented at the 85th Annual Meeting of The Endocrine Society; June 19-22, 2003; Philadelphia, Pennsylvania. Abstract 444.
10. Sacerdote AS. Modification of expression of non-classical congenital adrenal hyperplasia by pioglitazone. Presented at the 86th Annual Meeting of The Endocrine Society; June 16-19, 2004; New Orleans, Louisiana. Abstract 569.
11. Bahtiyar G, Weiss K, Sacerdote AS. Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone. Endocr Pract. 2007;13:601-608.
12. Atabek ME, Kurtoǧlu S, Keskin M. Female pseudohermaphrodism due to classical 21-hydroxylase deficiency and insulin resistance in a girl with Turner syndrome. Turk J Pediatr. 2005;47:176-179.
13. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia. 1999;42:678-687.
14. Arslanian SA, Lewy V, Danadian K, Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endoc Metab. 2002;87:1555-1559.
15. Kelly SN, McKenna TJ, Young LS. Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal. J Endocrinol. 2004;181:355-365.